Page 17 - Hikma - Oncology booklet
P. 17
Indication
Click to edit Master title style
Chronic Myeloid Leukemia (CML)
Myelodysplastic Syndromes
Chordomas
Chronic Eosinophilic Leukemia (CEL)
Desmoid Tumors
Contra Indication
In patients with hypersensitivity to imatinib
Dosage
Chronic Myelogenous Leukemia
600 Orally once a day 400 Orally 2 times a day
mg mg
Chronic phase Accelerated phase or blast crisis
Acute Lymphoblastic Leukemia
600
mg Orally once a day
18/01/2020 1
16
